|
[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-20 00:00:00 |
| Sponsor | Synovo GmbH;Paul-Ehrlich-Str. 15, D-72076 Tubingen; |
